Erratum to ‘Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial’ [European Journal of Cancer, Volume 124 (January 2020) Pages 91-101]
Titel:
Erratum to ‘Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial’ [European Journal of Cancer, Volume 124 (January 2020) Pages 91-101]
Auteur:
Hammel, Pascal Portales, Fabienne Mineur, Laurent Metges, Jean-Philippe Andre, Thierry De La Fouchardiere, Christelle Louvet, Christophe El Hajbi, Farid Faroux, Roger Guimbaud, Rosine Tougeron, David Bouche, Olivier Lecomte, Thierry Rebischung, Christine Tournigand, Christophe Cros, Jerome Kay, Richard Hamm, Adam Gupta, Anu Bachet, Jean-Baptiste El Hariry, Iman